2013 Newsletters

Never Giving Up After Failure Will Lead to Success

You have to work through the “wrong” ones to get to the “right” one. What does that make you think of? It makes me think of 2 things: 1) Relationships, and 2) Drug Development. I know, you’re thinking, “huh?”

Read More

PreClinical CROs – Why, When, Who, and How?

When I started my company 7 years ago, I knew I would eventually need HR support and capabilities. I didn’t want to do it myself for a couple reasons . . . I didn’t have the experience or knowledge in HR (Nor do I want it, no offense to any HR friends!), and I didn’t have the set-up/capabilities to be able to do it. I ended up choosing an outside company and outsourced all of my HR needs/functions to them. Easy right? Nope! I had to consider . . . Do I really need them? When do I engage them? Who should I choose? How do I initiate and oversee them?

Read More

Orphan Drugs—Are They Worth It?

Nearly a year ago, I was scrolling through my news feed on Facebook (yes, one of my guilty pleasures!) and came across a very disturbing picture of a newborn with horrible blisters and open sores all over his body. With immediate heart ache, I had to know his story . . . I found out he was suffering from Epidermolysis Bullosa (EB), a rare genetic disorder that causes the skin to be so fragile that the slightest touch or friction can cause severe and painful blistering—internally and externally.

Read More

Startups and the Role of the “Other” Development

I would like to introduce you all to a favorite colleague of McCormick LifeScience Consultants, LLC: Michael Kaiser, Life Sciences Executive. With over 25 years in the life sciences industry, Michael specializes in commercial development solutions based on team leadership, building business alliances and finding and developing the right opportunities for deals that meet the challenging demands of life sciences companies in the areas of corporate development and IP licensing strategies.

Read More

The Successful Life Science Company: Three Tips to Insure You Survive Your Success

Let’s welcome back a favorite colleague of McCormick LifeScience Consultants, LLC! As a friendly reminder, Mr. Andrew Johnson, PhD, Founder and President of UpStart Life Sciences, has twenty years of experience launching instruments, reagent kits, and software products into genomics, proteomics, and cell biology markets. Applying his business leadership and cell and molecular biology expertise, he has a unique perspective on how to bridge the gap between scientifically interesting technology and compelling commercial products.

Read More

The Quality Secret

Because he’s that good (oh yes), I’m bringing back one of my favorites . . . McCormick LifeScience Consultant LLC’s most brilliant (Mark, don’t let this go to your head) consultants, Mark Goodsell, a Quality professional with over 20 years GXP experience.

Read More

Where Does the Science Belong in the Life Science Start-Up?

I would like to introduce you all to a favorite colleague of McCormick LifeScience Consultants, LLC: Mr. Andrew Johnson, PhD, Founder and President of UpStart Life Sciences, has twenty years of experience launching instruments, reagent kits, and software products into genomics, proteomics, and cell biology markets. Applying his business leadership and cell and molecular biology expertise, he has a unique perspective on how to bridge the gap between scientifically interesting technology and compelling commercial products.

Read More

You Catch More Flies with Honey

I would like to introduce you to one of McCormick LifeScience Consultant LLC’s most brilliant (Mark, if you’re reading, please take a bow) consultants, Mark Goodsell. Mark has worked within the Quality field for over 20 years, with GXP experience in both biologics and small molecule from development through commercial stages. Mark is currently a consultant specializing in establishing Quality Systems within development organizations that are registration driven.

Read More

Never Giving Up After Failure Will Lead to Success

You have to work through the “wrong” ones to get to the “right” one. What does that make you think of? It makes me think of 2 things: 1) Relationships, and 2) Drug Development. I know, you’re thinking, “huh?”

Read More